Factors contributing to solubility synergism of some basic drugs with β-cyclodextrin in ternary molecular complexes

Journal of Inclusion Phenomena

Volumn 54, Issue 3-4, 2006, Pages 159-164

  Al Omari, Mahmoud M ^a   Zughul, Mohammad B ^b   Davies, J Eric D ^c   Badwan, Adnan A ^a  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

cyclodextrin; Basic drug; Inclusion complexation; Multicomponent; Solubility synergism

Indexed keywords

EID: 33646485241     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-005-6287-y     Document Type: Article

References (25)

1. J. Szejtli: Chem. Rev. 98, 1743 (1998).
2. A.Y. Tinwalla, B.L. Hoesterey, T. Xiang, K. Lim, and B.D. Anderson: Pharm. Res. 10, 1136 (1993).
3. M.T. Esclusa-Diaz, M. Gayo-Otero, M.B. Perez-Marcos, J.K. Vila-Jato, and J.J. Torres-Labandeira: Int. J. Pharm. 142, 183 (1996).
4. Y. Kim, D.A. Oksanen, W. Massefski, J.F. Blake, E.M. Duffy, and B. Chrunyk: J. Pharm. Sci. 87, 1560 (1998).
5. G. Ping, S.E. Tabibi, and S.H. Yalkowsky: J. Pharm. Sci. 87, 1535 (1998).
6. R. McCandless and S.H. Yalkowsky: J. Pharm. Sci. 87, 1639 (1998).
7. G. Piel, B. Evrard, M. Fillet, G. Llabres, and L. Delattre: Int. J. Pharm. 169, 15 (1998).
8. G. Piel, B. Evrard, T. VanHees, G. Llabres, and L. Delattre: STP Pharm. Sci. 9, 257 (1999).
9. B. Evard, P. Chiap, P. DeTullio, F. Ghalmi. G. Piel, T. Van Hees, J. Crommen, B. Losson, and L. Delattre: J. Control. Release 85, 45 (2002).
10. J.J. Garcia, F. Bolas, and J.J. Torrado: Int. Pharm J. 250, 351 (2003).
11. R. Casella, D.A. Williams, and S.S. Jambhekar: Int. J. Pharm. 165, 15 (1998).
12. E. Redenti, L. Szente, and J. Szejtli: J. Pharm. Sci. 90, 979 (2001).
13. P. Mura, F. Maestrelli, and M. Cirri: Int. J. Pharm. 260, 293 (2003).
14. A.A. Badwan, A. Abu-Malooh, M. Haddadin, and H. Ibrahim: US Patent No. 5646131 A 19970708 (1997).
15. H.M. Cabral, M.J. Hadgraft, and I.W. Kellawy: Int. J. Pharm. 63, 259 (1990).
16. L. Szente, J. Szejtli, M. Vikmon, J. Szeman, E. Fenyvesy, M. Pasini, E. Redenti, and P. Ventura: Proceedings of the 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, APGI, Chatenary Malabry (France) (1995), pp. 579-580.
17. Ventura P. Ventura, P. Chiesi, M. Pasini, E. Redenti, J. Szejtli, and M. Vikmon: US Patent No. US5855916 (1995).
18. G. Piel, B. Pirotte, I. Delneuville, P. Neven, G. Llabres, J. Delarge, and L. Delattre: J. Pharm. Sci. 86, 475 (1997).
19. E. Redenti, L. Szente, and J. Szejtli: J. Pharm. Sci. 89, 1 (2000).
20. BP (British Pharmacopoeia). Volume IV, Appendix V F p A181-A182. British Pharmacopoeia Commission, London (2003).
21. T. Higuchi and K.A. Connors: In C.N. Reilley (ed.), Advances in Analytical Chemistry and Instrumentation, Wiley-Interscience, New York (1965), pp. 117-212.
22. M.B. Zughul and A.A. Badwan: J. Incl. Phenom. 31, 243 (1998).
23. M.B. Zughul and A.A. Badwan: Int. J. Pharm. 151, 109 (1997).
24. M.B. Zughul, M. Al-Omari, and A.A. Badwan: Pharm. Dev. Technol. 3, 43 (1998).
25. E. Fenyvesi, M. Vikmon, J. Szeman, E. Redenti, M. Delcanale, P. Ventura, and J. Szejtli: J. Incl. Phenom. 33, 339 (1999).